Advertisement

Non-imaging radiopharmaceuticals

  • Azuwuike Owunwanne
  • Mohan Patel
  • Samy Sadek

Abstract

The non-imaging radiopharmaceuticals described in this chapter include 51Cr-RBCs, 57/58Co-vitamin B12, 59Fe citrate, 125I-HSA and 125I-fibrinogen. Details of procedures and calculations involving the use of these radioactive tracers are included for practical uses.

Keywords

Bile Acid Polycythemia Vera Pernicious Anemia Total Blood Volume ICRP Publication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Heisterkamp, D. and Ebaugh, F.G. (1962) Site of attachment of the Chromate ion to the haemoglobin molecule. Nature, 193, 1253–55.CrossRefGoogle Scholar
  2. 2.
    Sharma, S.M., Patel, M.C., Ramnathan, P. et al (1970) A new technique to denature red cells for spleen scanning. J. Nucl. Med., 11, 228–32.Google Scholar
  3. 3.
    International Committee for Standardisation in Hematology (1971) Recommended methods for radioisotope red cell survival studies. Blood, 38, 378–86.Google Scholar
  4. 4.
    Najean, Y., Cacchione, R., Dresch, C. and Rain, J.D. (1975) Methods of evaluating the sequestration site of red cells labeled with 51Cr: a review of 96 cases. Br. J. Haematol., 29, 495–510.CrossRefGoogle Scholar
  5. 5.
    ICRP Publication No. 53 (1990) Radiation Dose to Patients from Radiopharmaceuticals, Pergamon Press, Oxford, p. 106.Google Scholar
  6. 6.
    International Committee for Standardisation in Haematology (1980) Recommended methods for radioisotope red cell survival studies. Br. J. Haematol., 45, 659–66.CrossRefGoogle Scholar
  7. 7.
    Lehninger, A.L., (1975) Vitamins and coenzymes, in Biochemistry (ed. A.L. Lehninger), Worth Publishing, New York, pp. 335–36.Google Scholar
  8. 8.
    ICRP Publication No. 53 (1990) Radiation Dose to Patients from Radiopharmaceuticals, Pergamon Press, Oxford, pp. 133–34.Google Scholar
  9. 9.
    Katz, J.H., dMase, J. and Donaldson, R.M. (1963) Simultaneous administration of gastric juice bound and free radioactive cyanocobal-amin; rapid procedure for differentiating between intrinsic factor deficiency and other causes of vitamin B12 metabolism. J. Lab. Clin. Med., 61, 266–71.Google Scholar
  10. 10.
    Lionel, S.Z. and Rao, C. (1984) Schilling evaluation of pernicious anemia: current status. J. Nucl. Med., 25, 1032–39.Google Scholar
  11. 11.
    Peters, A.M. and Lewis, S.M. (1991) Hematology in Clinical Nuclear Medicine (eds M.N. Maisey, K.E. Britton and D.L. Gilday), J.B. Lippincott, London, pp. 346–82.Google Scholar
  12. 12.
    ICRP Publication No. 53. (1990) Radiation Dose to Patients from Radiopharmaceuticals, Pergamon Press, Oxford, pp. 119–24.Google Scholar
  13. 13.
    Monks, R and Thomas, I.L. (1982) 75Se labelled bile acid analogues. J. Labelled Compounds Radiopharmacol., 20, 463–86.CrossRefGoogle Scholar
  14. 14.
    Heaton, K.W. (1976) Clinical aspects of bile acid metabolism. Rec. Adv. Gastroenterol., 3, 199–230.Google Scholar
  15. 15.
    Boyd, G.S., Merrick, M.V., Monks, R. and Thomas, I.L. (1981) 75Se-labelled bile acid analogues. New radiopharmaceuticals for investigating the enterohepatic circulation. J. Nucl. Med., 22, 720–25.Google Scholar
  16. 16.
    Jazrawi, R.P., Lanzini, A., Britten, A. et al. (1984) Dynamics of gall bladder function and of the enterohepatic circulation studied γ bile acid. Clin. Sci., 66, 10P.Google Scholar
  17. 17.
    Merrick, M.V., Eastwood, M.A. and Ford J.J. (1985) Is bile acid malabsorption underdiagnosed? An evaluation of accuracy of diagnosis of measurement of Se HCAT retention. B.M.J., 290, 665–68.CrossRefGoogle Scholar
  18. 18.
    Nyhlin, H., Merrick, M.V., Eastwood, M.A. and Brydan, W.G. (1983) Evaluation of ileal function using 23-selena-25-homo taurocholate, a γ-labeled conjugated bile acid. Gastroenterology, 84, 63–8.Google Scholar
  19. 19.
    Merrick, M.V., Eastwood, M.A., Anderson, J.R. and Ross, H. McL (1982) Enterohepatic circulation in man of a gamma-emitting bile acid conjugate, 23-selena-25-hamotaurocholic acid (SeHCAT). J. Nucl. Med., 23, 126–30.Google Scholar
  20. 20.
    Delhez, H., van den Berg, J.W.O., Blankenstein, M. and Meerwaldt, J.H. (1982) New method for the determination of bile acid turnover using 75Se homocholic acid taurine. Eur. J. Nucl. Med., 7, 269–71.CrossRefGoogle Scholar
  21. 21.
    ICRP Publication No. 53 (1990) Radiation dose to patients from radiopharmaceuticals. Pergamon Press, Oxford, pp. 153–54.Google Scholar
  22. 22.
    Hunter, W.M. (1966) Iodination of protein compounds, in Radioactive Pharmaceuticals (eds G.A. Andrews, R.M. Kniseley and H.N. Wagner Jr), US Atomic Energy Commission, Oak Ridge, pp. 245–63.Google Scholar
  23. 23.
    Takeda, Y. and Reeve, E.B. (1963) Studies of the metabolism and distribution of albumin with autologus 131I albumin in healthy man. J. Lab. Clin. Med., 61, 183–202.Google Scholar
  24. 24.
    Hibbard, B.M. and Herbert, R.J.T. (1960) Foetal radiation dose following administration of radioiodinated albumin. Clin. Sci., 19, 337–44.Google Scholar
  25. 25.
    ICRP Publication No. 53 (1990) Radiation Dose to Patients from Radiopharmaceuticals, Pergamon Press, Oxford, pp. 285–87.Google Scholar
  26. 26.
    Welch, M.J. and Krohn, K.A. (1975) Critical review of radiolabeled fibrinogen, in Radio pharmaceuticals (eds G. Subramanian, B.A. Rhodes, J.F. Cooper, and V.J. Sodd), The Society of Nuclear Medicine, New York, pp. 493–502.Google Scholar
  27. 27.
    Loberg, M., Miller, I. and Cooper, M. (1975) Radioiodinated autologus fibrinogen: a rapid method of preparation for clinical use, in Radiopharmaceuticals (eds G. Subramanian, B.A. Rhodes, J.F. Cooper, and V.J. Sodd), The Society of Nuclear Medicine, New York pp. 503–13.Google Scholar
  28. 28.
    Product Information (1992) Iodinated [135I] human fibrinogen. Amersham International, UK.Google Scholar
  29. 29.
    Kakkar, V.V., Howe, C.T., Nicolaides, A.N. et al. (1970) Deep vein thrombosis of the leg. Am. J. Surg., 120, 527–30.CrossRefGoogle Scholar
  30. 30.
    Regoeczi E. (1971) The clottability of iodinated fibrinogen. J. Nucl. Biol. Med., 15, 37–41.Google Scholar
  31. 31.
    Regoeczi E. (1971) Iodine-labeled fibrinogen. A review. Br. J. Haemotol., 20, 649–63.CrossRefGoogle Scholar
  32. 32.
    ICRP Publication No. 53. (1990) Radiation Dose to Patients from Radiopharmaceuticals, Pergamon Press, Oxford, pp. 281–83.Google Scholar

Copyright information

© Azuwuike Owunwanne, Mohan Patel and Samy Sadek 1995

Authors and Affiliations

  • Azuwuike Owunwanne
    • 1
  • Mohan Patel
    • 2
  • Samy Sadek
    • 3
  1. 1.Department of Nuclear Medicine, Faculty of MedicineKuwait UniversityKuwait
  2. 2.Kuwait Central Radiopharmacy Kuwait Cancer Control CenterMinistry of Public HealthKuwait
  3. 3.Department of Nuclear Medicine Faculty of MedicineKuwait UniversityKuwait

Personalised recommendations